<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01197027</url>
  </required_header>
  <id_info>
    <org_study_id>HPTN062</org_study_id>
    <nct_id>NCT01197027</nct_id>
  </id_info>
  <brief_title>Feasibility and Acceptability Study of an Individual-Level Behavioral Intervention for Individuals With Acute and Early HIV-Infection</brief_title>
  <acronym>HPTN062</acronym>
  <official_title>Feasibility and Acceptability Study of an Individual-Level Behavioral Intervention for Individuals With Acute and Early HIV-Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HIV Prevention Trials Network</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>HIV Prevention Trials Network</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the acceptability and feasibility of an enhanced,
      individual-level counseling intervention for individuals in the acute and early phase of HIV
      infection aimed at reducing risk behaviors.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2010</start_date>
  <completion_date type="Actual">April 2012</completion_date>
  <primary_completion_date type="Actual">March 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of participants in the experimental arm who receive the first four intervention sessions between enrollment and week 2 visit</measure>
    <time_frame>Week 2</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of self-reported unprotected sex acts</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Acute HIV Infection</condition>
  <arm_group>
    <arm_group_label>Enhanced counseling</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>5 intensive counseling sessions following acute HIV infection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard counseling</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard HIV counseling following acute HIV infection</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Standard counseling</intervention_name>
    <description>Standard HIV counseling</description>
    <arm_group_label>Enhanced counseling</arm_group_label>
    <arm_group_label>Standard counseling</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Be enrolled in CHAVI 001 Note: The inclusion and exclusion criteria for CHAVI 001 are
             provided below. The criteria will not be reassessed prior to enrollment in HPTN 062.

          -  Inclusion Criteria from CHAVI 001

               -  Men and women aged â‰¥ 18 years at the time of screening.

               -  Able and willing to provide adequate information for locator purposes.

               -  Hemoglobin &gt; 10.0 g/dL.

               -  Willing to receive HIV test results.

               -  Not intending to relocate out of the area for the duration of study participation
                  and does not have a job or other obligations that may require long absences from
                  the area.

               -  Has acute HIV infection. (See Section 2.3 for definition).

        Exclusion Criteria:

          -  Any prior or current use of antiretroviral therapy (ART). This does not apply to
             individuals screening for Group 1A. ART use for the prevention of perinatal
             transmission may be waived after prior consultation with the protocol team.

               -  Previous or current participation in a HIV vaccine study. HPTN 062 Version 3.0
                  Final 03 August 2010

               -  Any condition that, in the opinion of the Investigator of Record, would make
                  participation in the study unsafe, complicate interpretation of study outcome
                  data, or otherwise interfere with achieving the study objectives.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amy Corneli, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>FHI 360</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Audrey Pettifor, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>FHI 360</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francis Martinson, Md, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kamuzu Central Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kamuzu Central Hospital</name>
      <address>
        <city>Lilongwe</city>
        <country>Malawi</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Malawi</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 7, 2010</study_first_submitted>
  <study_first_submitted_qc>September 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2010</study_first_posted>
  <last_update_submitted>June 4, 2012</last_update_submitted>
  <last_update_submitted_qc>June 4, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 6, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>HIV Infections</mesh_term>
    <mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

